Semaglutide, 5 mg

Semaglutide 5 mg injectable pen – a high-purity, research-grade peptide in a convenient prefilled pen designed for precise and consistent dosing in laboratory settings. A GLP-1 receptor agonist, widely studied for its role in glucose metabolism, insulin signalling, appetite regulation, and body weight pathways. Researchers explore its potential in metabolic function, weight regulation models, and endocrine system studies.

Research Reference:

Example experimental range: 
Weeks 1–4: 25 units per week.
Weeks 5–8: 50 units per week.
Weeks 9–52: Maximum 100 units per week, maintaining this level up to 1 year.

This information is provided strictly for research and educational purposes only. Not for human or animal use.